Dutch gastric cancer trial

The difference in curative resectability rate was 6. PD was more often the reason for not completing the planned four courses than toxicity. Substances Doxorubicin Fluorouracil Methotrexate. Surgical Co-operative Group. Br J Cancer ; 79 : — Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in Dutch patients.

Lancet ; : — Surgical treatment of gastric cancer: year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol ; 11 : — Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol ; 22 : — Morbidity and mortality in the Italian Gastric Cancer Study Group randomized clinical trial of D1 versus D2 resection for gastric cancer.

Br J Surg ; 97 : — Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer. Br J Surg ; : 23 — Nodal dissection for patients with gastric cancer: a randomized controlled trial. Lancet Oncol ; 7 : — D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer.

Evaluation of the extent of lymphadenectomy in a randomized trial of Western- versus Japanese-type surgery in gastric cancer. J Clin Oncol ; 12 : — The general rules for gastric cancer study in surgery and pathology. Jpn J Surg ; 11 : — Lymph node counts in the upper abdomen: anatomical basis for lymphadenectomy in gastric cancer.

Br J Surg ; 78 : — Extended lymph-node dissection for gastric cancer. Gastric cancer — seminar. Low Maruyama index surgery for gastric cancer: blinded reanalysis of the Dutch D1—D2 trial. World J Surg ; 29 : — Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer; the effect of undertreatment. Ann Surg Oncol ; 9 : — Oxford University Press is a department of the University of Oxford. It furthers the University's objective of excellence in research, scholarship, and education by publishing worldwide.

Sign In or Create an Account. Sign In. Advanced Search. Search Menu. Article Navigation. Close mobile search navigation Article Navigation. Volume Article Contents Abstract. Quality control of lymph node dissection in the Dutch Gastric Cancer Trial. Correspondence to : Dr W.

Oxford Academic. H H Hartgrink. J L Dikken. Department of Surgery, Medical Centre Haaglanden. H Putter. C J H van de Velde.

Revision received:. Select Format Select format. Permissions Icon Permissions. Abstract Background. Open in new tab Download slide. Table 1 Protocol deviations. Lymph node yield per station. Indication for dissection of station. Open in new tab. Table 2 Patient characteristics. Henk H. Cornelis J. Author information Article notes Copyright and License information Disclaimer.

Corresponding author. Received May 27; Accepted Jul This article has been cited by other articles in PMC. Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author s and source are credited.

References 1. Tanizawa Y, Terashima M. Lymph node dissection in the resection of gastric cancer: review of existing evidence. Bonenkamp JJ, et al.

Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in Dutch patients. Cuschieri A, et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group.

Hartgrink HH, et al. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol. Songun I, et al. Surgical treatment of gastric cancer: year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol. Morbidity and mortality in the Italian Gastric Cancer Study Group randomized clinical trial of D1 versus D2 resection for gastric cancer. Br J Surg. Krijnen P, et al. Improved survival after resectable non-cardia gastric cancer in The Netherlands: the importance of surgical training and quality control.

Eur J Surg Oncol. Birkmeyer JD, et al. Hospital volume and surgical mortality in the United States.